Search

Your search keyword '"Elsada, A."' showing total 146 results

Search Constraints

Start Over You searched for: Author "Elsada, A." Remove constraint Author: "Elsada, A."
146 results on '"Elsada, A."'

Search Results

3. Comparative Efficacy of Teclistamab Versus Current Treatments in Real-World Clinical Practice in the Prospective LocoMMotion Study in Patients with Triple-Class-Exposed Relapsed and/or Refractory Multiple Myeloma

4. The Colonial Legacy and the Jamaican Healthcare System

18. A registry study of relapsed or refractory multiple myeloma pre‐exposed to three or more prior therapies including a proteasome inhibitor, an immunomodulatory agent and CD38‐targeted monoclonal antibody therapy in England

19. Ideas from the Global South: Dependency and Decoloniality.

24. POSTER: CT-107 Cost-Effectiveness of the Chimeric Antigen Receptor (CAR) T-Cell Treatments, Lisocabtagene Maraleucel (liso-cel) Versus Axicabtagene Ciloleucel (axicel), as Second-Line (2L) Treatment of Large B-Cell Lymphoma (LBCL)

25. CT-107 Cost-Effectiveness of the Chimeric Antigen Receptor (CAR) T-Cell Treatments, Lisocabtagene Maraleucel (liso-cel) Versus Axicabtagene Ciloleucel (axi-cel), as Second-Line (2L) Treatment of Large B-Cell Lymphoma (LBCL)

27. PENGARUH SPIRITUALITAS DAN KECERDASAN EMOSIONAL TERHADAP KESEJAHTERAAN KARYAWAN DENGAN PERILAKU MENYIMPANG DITEMPAT KERJA SEBAGAI PEMODERASI

28. Analisis Perkembangan Pengenalan Satwa Prioritas Indonesia Pada Pendidikan Anak dengan Vosviewer

30. Comparative Efficacy of Teclistamab Versus Current Treatments in Real-World Clinical Practice in the Prospective LocoMMotion Study in Patients with Triple-Class-Exposed Relapsed and/or Refractory Multiple Myeloma

31. Serum levels of cortisol and prolactin in patients treated under total intravenous anesthesia with propofol-fentanyl and under balanced anesthesia with isoflurane-fentanyl

34. OAB-054: Comparative efficacy of teclistamab versus real-world physician’s choice of therapy in the prospective LocoMMotion study in patients with triple-class exposed relapsed/refractory multiple myeloma

35. Comparative efficacy of teclistamab (tec) versus current treatments (tx) in real-world clinical practice in the prospective LocoMMotion study in patients (pts) with triple-class exposed (TCE) relapsed/refractory multiple myeloma (RRMM).

36. P935: REAL WORLD COMPARATIVE ANALYSIS OF THE EFFICACY OF TECLISTAMAB VERSUS CURRENT TREATMENTS IN PATIENTS WITH TRIPLE-CLASS EXPOSED RELAPSED/REFRACTORY MULTIPLE MYELOMA FROM THE LOCOMOTION STUDY

37. The Health Care System in Jamaica

38. The Colonial Legacy and the Jamaican Healthcare System

39. OAB-054: Comparative efficacy of teclistamab versus real-world physician’s choice of therapy in the prospective LocoMMotion study in patients with triple-class exposed relapsed/refractory multiple myeloma

43. Comparative efficacy of teclistamab (tec) versus current treatments (tx) in real-world clinical practice in the prospective LocoMMotion study in patients (pts) with triple-class exposed (TCE) relapsed/refractory multiple myeloma (RRMM)

44. A registry study of relapsed or refractory multiple myeloma pre-exposed to three or more prior therapies including a proteasome inhibitor, an immunomodulatory agent and CD38-targeted monoclonal antibody therapy in England

47. Bacterial Vaginosis Presence in Sexually Active Women in Tuzla Canton Area

48. Importance of screening in the prevention of emergence and spread of MDR bacteria

49. Population Adjustment Methods for Indirect Comparisons : A Review of National Institute for Health and Care Excellence Technology Appraisals

50. KEBIASAAN KONSUMSI ALKOHOL DAN KEJADIAN HIPERTENSI PADA LAKI-LAKI USIA 35-59 TAHUN DI KOTA BITUNG

Catalog

Books, media, physical & digital resources